Sonoma Pharmaceuticals Inc (SNOA)
NASDAQ
The current SNOA market cap is 3.67M. The company's latest EPS is USD -3.6104 and P/E is -0.76.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 2.73M | 3.14M | 3.44M | 3.39M | 3.58M |
Operating Income | -1.21M | -844k | -1.41M | -1.17M | -850k |
Net Income | -1.48M | -866k | -1.07M | -1.14M | -610k |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 18.94M | 18.63M | 12.63M | 13.27M | 12.74M |
Operating Income | -6.67M | -3.45M | -5.89M | -4.57M | -4.7M |
Net Income | -2.95M | -3.95M | -5.09M | -5.15M | -4.84M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 13.64M | 14.62M | 14.74M | 13.67M | 13.69M |
Total Liabilities | 7.96M | 7.93M | 8.6M | 8.7M | 8.33M |
Total Equity | 5.68M | 6.69M | 6.14M | 4.98M | 5.35M |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 14.56M | 14.99M | 18.85M | 16.23M | 14.74M |
Total Liabilities | 5.86M | 9.62M | 10.15M | 8.25M | 8.6M |
Total Equity | 8.71M | 5.36M | 8.7M | 7.98M | 6.14M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -1.45M | -2.55M | -2.4M | -912k | -558k |
Investing | -19k | -20k | -2k | -5k | -31k |
Financing | -264k | 1.05M | 1.68M | 636k | 2.08M |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -4.54M | -3.38M | -4.25M | -6.15M | -2.4M |
Investing | 3.59M | 388k | -99k | -258k | -2k |
Financing | 1.03M | 3.31M | 7.4M | 2.49M | 1.68M |
Market Cap | 3.67M |
Price to Earnings Ratio | -0.76 |
Price to Sales Ratio | 0.29 |
Price to Cash Ratio | 1.18 |
Price to Book Ratio | 0.6 |
Dividend Yield | - |
Shares Outstanding | 1.34M |
Average Volume (1 week) | 100.62k |
Average Volume (1 Month) | 57.52k |
52 Week Change | -23.16% |
52 Week High | 9.374 |
52 Week Low | 2.44 |
Spread (Intraday) | 0.61 (20.13%) |
Company Name | Sonoma Pharmaceuticals Inc |
Address |
850 new burton road dover, delaware 19904 |
Website | https://www.sonomapharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.